- Home
- OXLCO vs CYCCP Comparison
OXLCO vs CYCCP Comparison
Compare OXLCO & CYCCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OXLCO
- CYCCP
- Stock Information
- Founded
- OXLCO N/A
- CYCCP N/A
- Country
- OXLCO United States
- CYCCP United States
- Employees
- OXLCO N/A
- CYCCP 12
- Industry
- OXLCO Investment Managers
- CYCCP Biotechnology: Pharmaceutical Preparations
- Sector
- OXLCO Finance
- CYCCP Health Care
- Exchange
- OXLCO Nasdaq
- CYCCP Nasdaq
- Market Cap
- OXLCO N/A
- CYCCP N/A
- IPO Year
- OXLCO N/A
- CYCCP N/A
- Fundamental
- Price
- OXLCO $22.94
- CYCCP $7.04
- Analyst Decision
- OXLCO
- CYCCP
- Analyst Count
- OXLCO 0
- CYCCP 0
- Target Price
- OXLCO N/A
- CYCCP N/A
- AVG Volume (30 Days)
- OXLCO N/A
- CYCCP N/A
- Earning Date
- OXLCO N/A
- CYCCP N/A
- Dividend Yield
- OXLCO N/A
- CYCCP N/A
- EPS Growth
- OXLCO N/A
- CYCCP N/A
- EPS
- OXLCO N/A
- CYCCP N/A
- Revenue
- OXLCO N/A
- CYCCP N/A
- Revenue This Year
- OXLCO N/A
- CYCCP N/A
- Revenue Next Year
- OXLCO N/A
- CYCCP N/A
- P/E Ratio
- OXLCO N/A
- CYCCP N/A
- Revenue Growth
- OXLCO N/A
- CYCCP N/A
- 52 Week Low
- OXLCO N/A
- CYCCP N/A
- 52 Week High
- OXLCO N/A
- CYCCP N/A
- Technical
- Relative Strength Index (RSI)
- OXLCO 56.62
- CYCCP 43.05
- Support Level
- OXLCO $22.79
- CYCCP $6.75
- Resistance Level
- OXLCO $22.92
- CYCCP $8.00
- Average True Range (ATR)
- OXLCO 0.07
- CYCCP 0.41
- MACD
- OXLCO 0.00
- CYCCP 0.07
- Stochastic Oscillator
- OXLCO 99.92
- CYCCP 50.77
About OXLCO Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.
About CYCCP Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.